Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 July 2020 | Story Nitha Ramnath | Photo istock

Date: 28 July 2020
Time: 14:00 – 15:30

Gender inequalities domestic violence and gender-based violence (GBV) are global concerns, and have been exacerbated by the impact of Covid-19 as women take on more child and care work responsibilities.  Jobs lost in service sectors often affect women most, large numbers of frontline health workers and teachers are women, and lockdowns increase domestic violence. Thus President Cyril Ramaphosa recently said in a televised address that more than 21 women and children have been murdered in South Africa within just a few weeks in what he referred to as “another pandemic raging in our country.” He said this “violence being unleashed on women and children with a brutality that defies comprehension, is no less than a war being waged against the women and children of our country”.

As the World Economic Forum points out, regardless of where one looks, it is women who bear most of the responsibility for holding societies together, be it at home, in health care, at school, or in caring for the elderly. In many countries, women perform these tasks without pay. 

Now, the Covid-19 pandemic is compounding existing gender inequalities, and increasing risks of gender-based violence. Gender inequality, layered along with the effects of the pandemic, lockdowns and the economic downturn, could leave a deep and lasting impact on the lives and opportunities of women and girls.

Given, then, that the COVID-19 crisis affects women and girls in different ways from men and boys, measures to resolve it must take gender into account, and the protection and promotion of the rights of women and girls prioritized. 
To take up these issues of gender inequalities and gender-based violence, two renowned gender research experts will take part in our webinar. The webinar will be chaired by Professor Melanie Walker of the University of the Free State.  The presenters are: Professor Pumla Gqola, Professor of Women and Gender Studies at Nelson Mandela University and author of Rape: A South African Nightmare. Lisa Vetten has worked in the field of violence against women for over two decades as a counsellor, para-legal, trainer and researcher. She is currently an honorary research associate at the Wits Institute for Social and Economic Research (WiSER).

Join us from 14:00 to 15:30 on 28 July. 

RSVP to Sibongile Mlotya at MlotyaS@ufs.ac.za no later than 26 July, upon which you will receive a Business for Skype meeting invite.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept